These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Molecular diagnosis of leukemia and lymphoma]. Iida S; Ueda R Rinsho Byori; 1994 Apr; 42(4):364-71. PubMed ID: 8176845 [TBL] [Abstract][Full Text] [Related]
6. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction]. Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019 [TBL] [Abstract][Full Text] [Related]
7. Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies. Gleissner B; Thiel E Expert Rev Mol Diagn; 2001 Jul; 1(2):191-200. PubMed ID: 11901814 [TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Cazzaniga G; Biondi A Haematologica; 2005 Mar; 90(3):382-90. PubMed ID: 15749670 [TBL] [Abstract][Full Text] [Related]
9. [The current status of leukemia genetic testing and the trial of its standardization]. Satoh Y; Yokota H; Kageyama Y; Ono Y; Yatomi Y Rinsho Byori; 2008 May; 56(5):395-401. PubMed ID: 18546889 [TBL] [Abstract][Full Text] [Related]
10. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Elia L; Mancini M; Moleti L; Meloni G; Buffolino S; Krampera M; De Rossi G; Foà R; Cimino G Haematologica; 2003 Mar; 88(3):275-9. PubMed ID: 12651265 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of minimal residual disease in leukemia, advantages and pitfalls. Cazzaniga G; Gaipa G; Rossi V; Biondi A Ann Med; 2006; 38(7):512-21. PubMed ID: 17101542 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432 [TBL] [Abstract][Full Text] [Related]
13. Detection of minimal residual disease in acute leukemia. van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219 [TBL] [Abstract][Full Text] [Related]
14. [Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia]. Liu HX; Zhu P; Zhang Y; Wang HX; DU JW; Liu J; Gu JY; Ou Y Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):526-32. PubMed ID: 17459201 [TBL] [Abstract][Full Text] [Related]
15. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma. Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345 [TBL] [Abstract][Full Text] [Related]
16. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978 [TBL] [Abstract][Full Text] [Related]
17. Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia. Hokland P; Pallisgaard N Semin Hematol; 2000 Oct; 37(4):358-67. PubMed ID: 11071358 [TBL] [Abstract][Full Text] [Related]
18. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia. Guggemos A; Eckert C; Szczepanski T; Hanel C; Taube T; van der Velden VH; Graf-Einsiedel H; Henze G; Seeger K Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551 [TBL] [Abstract][Full Text] [Related]
19. [In situ PCR in the diagnosis of acute leukemia]. Gjadrov Kuvezdić K; Sucić M; Boban D; Marković-Glamocak M; Ries S; Stavljenić-Rukavina A; Labar B Lijec Vjesn; 2000; 122(9-10):222-5. PubMed ID: 11210817 [TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients. Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]